Travere Therapeutics, Inc. (TVTX)
30.22
-0.10
(-0.33%)
USD |
NASDAQ |
Feb 11, 16:00
30.46
+0.24
(+0.79%)
After-Hours: 07:58
Travere Therapeutics EPS Diluted (Quarterly) : 0.2505 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 2.205 |
| Ligand Pharmaceuticals, Inc. | 5.685 |
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 25.71M |
| Revenue (Quarterly) | 164.86M |
| Total Expenses (Quarterly) | 139.15M |
| Enterprise Value | 2.779B |
| Gross Profit Margin (Quarterly) | 89.46% |
| Profit Margin (Quarterly) | 15.59% |
| Earnings Yield | -3.59% |
| Normalized Earnings Yield | -3.55 |